文献速递腹部CTMRUS

胰腺囊性肿瘤诊断与管理专家意见调查

Survey of Experts' Opinions on the Diagnosis and Management of Pancreatic Cystic Neoplasms.
PubMed 文献 · Korean J Radiol · 2024-11-08

该调查于2023年8月25日至10月5日通过电子邮件邀请韩国腹部放射学会和韩国胰胆协会成员参与,分析100名放射科医生和41名胰腺专科医生的回答,发现增强CT是最常用和首选的诊断方式,多数受访者遵循2017年国际胰腺病学协会指南,但在术语、鉴别诊断、影像检查不一致的处理及监测终止意见上存在差异。

要点

  • 增强CT是胰腺囊性肿瘤最常用和首选的诊断方式,87.8%(36/41)的胰腺专科医生首选增强CT。
  • 88.7%(125/141)的受访者在实践中遵循2017年国际胰腺病学协会指南。
  • 放射科医生中51.0%(51/100)认可强化壁结节5 mm为截断值,22.0%(22/100)支持5 mm/2年生长速率。

核心结论

  • 调查强调胰腺囊性肿瘤带来的临床负担,并确定增强CT为首要诊断工具;受访者整体及放射科医生与胰腺专科医生之间在术语、鉴别诊断、影像检查不一致的处理方法及监测终止意见上存在差异;尽管主要遵循2017年国际胰腺病学协会指南,但放射科医生对风险分层仍有一定程度的不满意。

研究设计与样本

  • 于2023年8月25日至2023年10月5日通过电子邮件邀请韩国腹部放射学会和韩国胰胆协会成员参与在线调查,分析100名放射科医生和41名胰腺专科医生的回答。

诊断标准与关键数值

  • 87.8%(36/41)的胰腺专科医生首选增强CT作为胰腺囊性肿瘤的诊断方式;放射科医生中51.0%(51/100)认可强化壁结节5 mm为截断值,22.0%(22/100)支持2017年国际胰腺病学协会指南中的5 mm/2年生长速率。

临床应用与阅片要点

  • 当增强CT或MRI与超声内镜结果不一致时,31.2%(44/141)的受访者选择多学科团队讨论,29.1%(41/141)选择使用增强CT或MRI进行短期随访;88.7%(125/141)的受访者在实践中遵循2017年国际胰腺病学协会指南。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To survey experts' opinions in abdominal radiology (radiologists) and pancreas-specialized gastroenterology (pancreatologists) in South Korea regarding diagnosing and managing pancreatic cystic neoplasms (PCNs).

MATERIALS AND METHODS: Between August 25, 2023, and October 5, 2023, an online survey was conducted among members of the Korean Society of Abdominal Radiology and the Korean Pancreatobiliary Association via email invitation.

RESULTS: The responses from 100 radiologists and 41 pancreatologists were analyzed. Of the respondents, 55.3% (78/141) reported seeing more than 50 patients or reading more than 50 exams related to PCN each month. The most common and preferred diagnostic modality for PCN was contrast-enhanced computed tomography (CECT), favored by 87.8% (36/41) of pancreatologists. When discrepancies arose between CECT or magnetic resonance imaging (MRI) and endoscopic ultrasound, 31.2% (44/141) of the respondents opted for multidisciplinary team discussion, whereas 29.1% (41/141) chose short-term follow-up using CECT or MRI. A total of 88.7% (125/141) of the respondents adhered to the 2017 International Association of Pancreatology (IAP) guidelines in their practice. Among the radiologists, 51.0% (51/100) endorsed a cut-off value of 5 mm for enhancing mural nodules, and 22.0% (22/100) supported a 5 mm/2 yr growth rate in the IAP guidelines v.2017. Additionally, 73.0% (73/100) of radiologists favored discontinuing surveillance, whereas 41.5% (17/41) of pancreatologists disagreed with stopping surveillance.

CONCLUSION: The survey underscores the clinical burden PCN poses and identifies CECT as the foremost diagnostic tool. Variability was noted in the terminology, differential diagnosis, approaches for resolving discrepancies between imaging examinations, and opinions on surveillance discontinuation among the respondents as a whole, as well as between radiologists and pancreatologists. Although the 2017 IAP guidelines are primarily followed, there remains a level of dissatisfaction with risk stratification among radiologists. This highlights the need for more standardized diagnostic algorithms and improved consensus among specialists to address these challenges.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Yoon JH, Cho IR, Chang W, et al. Survey of Experts' Opinions on the Diagnosis and Management of Pancreatic Cystic Neoplasms. Korean J Radiol. 2024. PMID: 39543866. doi:10.3348/kjr.2024.0626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。